5939 related articles for article (PubMed ID: 3117468)
1. Interferon-mediated enhancement of metastasis. Are MHC antigens involved?
Lollini PL; De Giovanni C; Del Re B; Nicoletti G; Prodi G; Nanni P
Clin Exp Metastasis; 1987; 5(4):277-87. PubMed ID: 3117468
[TBL] [Abstract][Full Text] [Related]
2. IFN-treatment of B16-F1 versus B16-F10: relative impact on non-adaptive and T-cell-mediated immune defense in metastatic spread.
Zöller M
Clin Exp Metastasis; 1988; 6(5):411-29. PubMed ID: 3132343
[TBL] [Abstract][Full Text] [Related]
3. Lung colonization and metastasis by disseminated B16 melanoma cells: H-2 associated control at the level of the host and the tumor cell.
Taniguchi K; Kärre K; Klein G
Int J Cancer; 1985 Oct; 36(4):503-10. PubMed ID: 4044058
[TBL] [Abstract][Full Text] [Related]
4. Augmentation of therapeutic antitumor immunity by B16F10 melanoma cells transfected by interferon-gamma and allogeneic MHC class I cDNAs.
Lim YS; Kang BY; Kim EJ; Kim SH; Hwang SY; Kim TS
Mol Cells; 1998 Oct; 8(5):629-36. PubMed ID: 9856353
[TBL] [Abstract][Full Text] [Related]
5. Modulation by IFN-gamma of the metastatic ability of murine, human, and H-2-transfected tumor cells.
Lollini PL; De Giovanni C; Nicoletti G; Scotlandi K; Landuzzi L; Nanni P
Tumori; 1989 Aug; 75(4):383-8. PubMed ID: 2510384
[TBL] [Abstract][Full Text] [Related]
6. Immunological and non-immunological influence of H-2Kb gene transfection on the metastatic ability of B16 melanoma cells.
De Giovanni C; Palmieri G; Nicoletti G; Landuzzi L; Scotlandi K; Bontadini A; Tazzari PL; Sensi M; Santoni A; Nanni P
Int J Cancer; 1991 May; 48(2):270-6. PubMed ID: 1902202
[TBL] [Abstract][Full Text] [Related]
7. Interferon gamma induces lung colonization by intravenously inoculated B16 melanoma cells in parallel with enhanced expression of class I major histocompatibility complex antigens.
Taniguchi K; Petersson M; Höglund P; Kiessling R; Klein G; Kärre K
Proc Natl Acad Sci U S A; 1987 May; 84(10):3405-9. PubMed ID: 3106968
[TBL] [Abstract][Full Text] [Related]
8. Interferon-gamma treatment of B16 melanoma cells: opposing effects for non-adaptive and adaptive immune defense and its reflection by metastatic spread.
Zöller M; Strubel A; Hämmerling G; Andrighetto G; Raz A; Ben-Ze'ev A
Int J Cancer; 1988 Feb; 41(2):256-66. PubMed ID: 3123403
[TBL] [Abstract][Full Text] [Related]
9. Impaired H-2 expression in B16 melanoma variants.
Nanni P; Colombo MP; De Giovanni C; Lollini PL; Nicoletti G; Parmiani G; Prodi G
J Immunogenet; 1983 Oct; 10(5):361-70. PubMed ID: 6644070
[TBL] [Abstract][Full Text] [Related]
10. Growth and metastasis in allogeneic hosts. Lack of H-2-negative or somatic hybrid variant selection.
De Giovanni C; Lollini PL; Nicoletti G; Del Re B; Scotlandi K; Prodi G; Nanni P
Exp Clin Immunogenet; 1987; 4(3):153-62. PubMed ID: 3273420
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of experimental metastatic ability by tumor necrosis factor-alpha alone or in combination with interferon-gamma.
Lollini PL; De Giovanni C; Nicoletti G; Bontadini A; Tazzari PL; Landuzzi L; Scotlandi K; Nanni P
Clin Exp Metastasis; 1990; 8(2):215-24. PubMed ID: 2107993
[TBL] [Abstract][Full Text] [Related]
12. Relationship between inducible H-2 expression and the immunogenicity of murine skin neoplasms. I. Evidence that the immunogenicity of ultraviolet radiation-chemically induced tumors is associated with their susceptibility to gamma-interferon-mediated enhancement of H-2Kk expression.
Burnham DK; Mak CK; Webster RJ; Daynes RA
Transplantation; 1989 Mar; 47(3):533-42. PubMed ID: 2493701
[TBL] [Abstract][Full Text] [Related]
13. Interferon-induced alterations in metastatic capacity, class-1 antigen expression and natural killer cell sensitivity of melanoma cells.
McMillan TJ; Rao J; Everett CA; Hart IR
Int J Cancer; 1987 Nov; 40(5):659-63. PubMed ID: 2445702
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of the antitumor effect of two types of murine recombinant interferons, (beta) and (gamma), against B16-F10 melanoma.
Sakurai M; Iigo M; Tamura T; Otsu A; Sasaki Y; Nakano H; Nakagawa K; Minato K; Ohe Y; Saijo N
Cancer Immunol Immunother; 1988; 26(2):109-13. PubMed ID: 3129191
[TBL] [Abstract][Full Text] [Related]
15. Modulation of murine tumor major histocompatibility antigens by cytokines in vivo and in vitro.
Weber JS; Rosenberg SA
Cancer Res; 1988 Oct; 48(20):5818-24. PubMed ID: 3139284
[TBL] [Abstract][Full Text] [Related]
16. Immunization by gamma-IFN-treated B16-F10.9 melanoma cells protects against metastatic spread of the parental tumor.
Porgador A; Brenner B; Vadai E; Feldman M; Eisenbach L
Int J Cancer Suppl; 1991; 6():54-60. PubMed ID: 1906054
[TBL] [Abstract][Full Text] [Related]
17. Interferon-mediated modulation of metastasis and MHC antigens.
Lollini PL; De Giovanni C; Del Re B; Nicoletti G; Prodi G; Scotlandi K; Nanni P
Adv Exp Med Biol; 1988; 233():129-39. PubMed ID: 3146902
[No Abstract] [Full Text] [Related]
18. Increased projection of MHC and tumor antigens in murine B16-BL6 melanoma induced by hydrostatic pressure and chemical crosslinking.
Ramakrishna V; Eisenthal A; Skornick Y; Shinitzky M
Cancer Immunol Immunother; 1993 May; 36(5):293-9. PubMed ID: 8477415
[TBL] [Abstract][Full Text] [Related]
19. Metastasis of mouse T lymphoma cells is controlled by the level of major histocompatibility complex class I H-2Dk antigens.
VandenDriessche T; Geldhof A; Bakkus M; Toussaint-Demylle D; Brijs L; Thielemans K; Verschueren H; De Baetselier P
Int J Cancer; 1994 Jul; 58(2):217-25. PubMed ID: 8026885
[TBL] [Abstract][Full Text] [Related]
20. Enhancing CTL responses to melanoma cell vaccines in vivo: synergistic increases obtained using IFNgamma primed and IFNbeta treated B7-1+ B16-F10 melanoma cells.
Dezfouli S; Hatzinisiriou I; Ralph SJ
Immunol Cell Biol; 2003 Dec; 81(6):459-71. PubMed ID: 14636243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
